N Vergnolle
Overview
Explore the profile of N Vergnolle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ader I, Penicaud L, Andrieu S, Beard J, Davezac N, Dray C, et al.
J Frailty Aging
. 2021 Sep;
10(4):313-319.
PMID: 34549244
The find solutions for optimizing healthy aging and increase health span is one of the main challenges for our society. A novel healthcare model based on integration and a shift...
2.
Santin Y, Lopez S, Ader I, Andrieu S, Blanchard N, Carriere A, et al.
J Frailty Aging
. 2021 Feb;
10(2):121-131.
PMID: 33575700
Aging is the major risk factor for the development of chronic diseases. After decades of research focused on extending lifespan, current efforts seek primarily to promote healthy aging. Recent advances...
3.
Guyonnet S, Rolland Y, Takeda C, Ousset P, Ader I, Davezac N, et al.
J Frailty Aging
. 2021 Feb;
10(2):110-120.
PMID: 33575699
Background: The Geroscience field focuses on the core biological mechanisms of aging, which are involved in the onset of age-related diseases, as well as declines in intrinsic capacity (IC) (body...
4.
de Souto Barreto P, Guyonnet S, Ader I, Andrieu S, Casteilla L, Davezac N, et al.
J Frailty Aging
. 2021 Feb;
10(2):86-93.
PMID: 33575696
Aging is the most important risk factor for the onset of several chronic diseases and functional decline. Understanding the interplays between biological aging and the biology of diseases and functional...
5.
Guerville F, de Souto Barreto P, Ader I, Andrieu S, Casteilla L, Dray C, et al.
J Prev Alzheimers Dis
. 2020 Feb;
7(1):56-64.
PMID: 32010927
The Geroscience aims at a better understanding of the biological processes of aging, to prevent and/or delay the onset of chronic diseases and disability as well as to reduce the...
6.
Bonnart C, Feuillet G, Vasseur V, Cenac N, Vergnolle N, Blanchard N
Parasite Immunol
. 2017 Sep;
39(11).
PMID: 28881035
Toxoplasma gondii is a widespread intracellular parasite, which naturally enters the organism via the oral route and crosses the intestinal barrier to disseminate. In addition to neuronal and ocular pathologies,...
7.
Bashashati M, Fichna J, Piscitelli F, Capasso R, Izzo A, Sibaev A, et al.
Neurogastroenterol Motil
. 2017 Jul;
29(12).
PMID: 28695708
Background: Endocannabinoid anandamide (AEA) inhibits intestinal motility and visceral pain, but it may also be proalgesic through transient receptor potential vanilloid-1 (TRPV1). AEA is degraded by fatty acid amide hydrolase...
8.
Monjotin N, Gillespie J, Farrie M, Le Grand B, Junquero D, Vergnolle N
Br J Pharmacol
. 2016 Apr;
173(14):2224-36.
PMID: 27111354
Background And Purpose: The aims of the present study were to characterize the role of PAR1 in rat bladder under inflammatory conditions and determine whether a selective PAR1 antagonist, F16357,...
9.
Cenac N, Castro M, Desormeaux C, Colin P, Sie M, Ranger M, et al.
Eur J Pain
. 2015 Nov;
20(5):723-30.
PMID: 26541237
Background: Trimebutine maleate, a noncompetitive spasmolytic agent with some affinity for peripheral μ- and κ-opioid receptors has been evaluated as a treatment in a limited number of patients undergoing sedation-free...
10.
Provost M, Bregeon J, Aubert P, Duchalais-Dassonneville E, dAldebert E, Vergnolle N, et al.
Neurogastroenterol Motil
. 2014 Nov;
27(1):40-50.
PMID: 25388954
Background: Sacral nerve stimulation (SNS) is a validated treatment for fecal incontinence, although the mechanism of action remains unknown. Short-term effects of SNS on the intestinal epithelial barrier (IEB) have...